Medpace Holdings Inc. (01P)
XSTU
Closed
Aug 24, 2026
Day's Range
518.8052 wk Range
334.00Overview - 01P - Medpace Holdings Inc.
Key Statistics
Valuation
P/E (Trailing)
‪33.74‬
PEG Ratio
‪0.92‬
Price / Book
‪34.27‬
Profitability
Gross Margin
‪28.50%‬
Profit Margin
‪30.06%‬
Operating Margin
‪21.14%‬
Return on Assets
‪22.83%‬
Return on Equity
‪98.26%‬
Ownership
Shares Outstanding
27.91M
Price stats
50-Day Avg
‪477.98‬
200-Day Avg
‪443.82‬
Peers - 01P - Medpace Holdings Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XSTU.
- 01PXSTUMedpace Holdings Inc.+27.29%52-week change32.21P/E (Trailing)‪30.06%‬Profit Margin
- NL0XSTUGrail, Inc.+57.60%52-week change-6.08P/E (Trailing)‪-236.94%‬Profit Margin
- 8YYXSTUCoro Energy plc+86.30%52-week change0.07P/E (Trailing)‪63.04%‬Profit Margin
- 0MEXSTUTwist Bioscience Corporation+77.96%52-week change-81.58P/E (Trailing)‪50.72%‬Profit Margin
- 6BU0XSTUBurning Rock Biotech Limited American Depositary Receipt+62.30%52-week change-1.34P/E (Trailing)‪74.67%‬Profit Margin
- ILUXSTUIllumina, Inc.+50.05%52-week change29.79P/E (Trailing)‪66.08%‬Profit Margin
- 12VXSTUVeracyte Inc.+49.99%52-week change54.75P/E (Trailing)‪70.10%‬Profit Margin
Profile Summary - 01P - Medpace Holdings Inc.
About
Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehensive clinical development support across phases I through IV,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
